Literature DB >> 20853017

Understanding the role of tumor stem cells in glioblastoma multiforme: a review article.

Aalya Fatoo1, Michael J Nanaszko, Baxter B Allen, Christina L Mok, Elena N Bukanova, Robel Beyene, Jennifer A Moliterno, John A Boockvar.   

Abstract

It has been hypothesized that cancer stem cells (CSC) may account for the pathogenesis underlying various tumors, including GBM. Markers of these CSCs can be potentially used as therapeutic targets. In this review, we discuss the most recent information regarding CSCs, their molecular biology and their potential role in GBM.

Entities:  

Mesh：

Year:  2010        PMID： 20853017     DOI： 10.1007/s11060-010-0406-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  112 in total

1.  A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.

Authors:  Ruihuan Chen; Merry C Nishimura; Stephanie M Bumbaca; Samir Kharbanda; William F Forrest; Ian M Kasman; Joan M Greve; Robert H Soriano; Laurie L Gilmour; Celina Sanchez Rivers; Zora Modrusan; Serban Nacu; Steve Guerrero; Kyle A Edgar; Jeffrey J Wallin; Katrin Lamszus; Manfred Westphal; Susanne Heim; C David James; Scott R VandenBerg; Joseph F Costello; Scott Moorefield; Cynthia J Cowdrey; Michael Prados; Heidi S Phillips
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

2.  Targeting cancer stem cells through L1CAM suppresses glioma growth.

Authors:  Shideng Bao; Qiulian Wu; Zhizhong Li; Sith Sathornsumetee; Hui Wang; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

3.  p53 suppresses the self-renewal of adult neural stem cells.

Authors:  Konstantinos Meletis; Valtteri Wirta; Sanna-Maria Hede; Monica Nistér; Joakim Lundeberg; Jonas Frisén
Journal:  Development       Date:  2006-01       Impact factor: 6.868

4.  Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro.

Authors:  Tatyana N Ignatova; Valery G Kukekov; Eric D Laywell; Oleg N Suslov; Frank D Vrionis; Dennis A Steindler
Journal:  Glia       Date:  2002-09       Impact factor: 7.452

5.  Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.

Authors:  Hiroaki Wakimoto; Santosh Kesari; Christopher J Farrell; William T Curry; Cecile Zaupa; Manish Aghi; Toshihiko Kuroda; Anat Stemmer-Rachamimov; Khalid Shah; Ta-Chiang Liu; Deva S Jeyaretna; Jason Debasitis; Jan Pruszak; Robert L Martuza; Samuel D Rabkin
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

6.  Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo.

Authors:  Sripathi M Sureban; Randal May; Robert J George; Brian K Dieckgraefe; Howard L McLeod; Satish Ramalingam; Kumar S Bishnupuri; Gopalan Natarajan; Shrikant Anant; Courtney W Houchen
Journal:  Gastroenterology       Date:  2008-03-04       Impact factor: 22.682

Review 7.  CD133: molecule of the moment.

Authors:  D Mizrak; M Brittan; M R Alison
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

8.  Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells.

Authors:  Gary L Gallia; Betty M Tyler; Christine L Hann; I-Mei Siu; Vincent L Giranda; Angelo L Vescovi; Henry Brem; Gregory J Riggins
Journal:  Mol Cancer Ther       Date:  2009-02-10       Impact factor: 6.261

9.  SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.

Authors:  Rosaria Maria Rita Gangemi; Fabrizio Griffero; Daniela Marubbi; Marzia Perera; Maria Cristina Capra; Paolo Malatesta; Gian Luigi Ravetti; Gian Luigi Zona; Antonio Daga; Giorgio Corte
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

10.  Wnt signalling regulates adult hippocampal neurogenesis.

Authors:  Dieter-Chichung Lie; Sophia A Colamarino; Hong-Jun Song; Laurent Désiré; Helena Mira; Antonella Consiglio; Edward S Lein; Sebastian Jessberger; Heather Lansford; Alejandro R Dearie; Fred H Gage
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962
View more
  11 in total

1.  Nanog increases focal adhesion kinase (FAK) promoter activity and expression and directly binds to FAK protein to be phosphorylated.

Authors:  Baotran Ho; Gretchen Olson; Sheila Figel; Irwin Gelman; William G Cance; Vita M Golubovskaya
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

Review 2.  Intra-arterial chemotherapy for malignant gliomas: a critical analysis.

Authors:  J-K Burkhardt; H A Riina; B J Shin; J A Moliterno; C P Hofstetter; J A Boockvar
Journal:  Interv Neuroradiol       Date:  2011-10-17       Impact factor: 1.610

3.  The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas.

Authors:  Elena Binda; Alberto Visioli; Fabrizio Giani; Giuseppe Lamorte; Massimiliano Copetti; Ken L Pitter; Jason T Huse; Laura Cajola; Nadia Zanetti; Francesco DiMeco; Lidia De Filippis; Annunziato Mangiola; Giulio Maira; Carmelo Anile; Pasquale De Bonis; Brent A Reynolds; Elena B Pasquale; Angelo L Vescovi
Journal:  Cancer Cell       Date:  2012-12-11       Impact factor: 31.743

Review 4.  Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment.

Authors:  Edjah Kweku-Ebura Nduom; Costas George Hadjipanayis; Erwin G Van Meir
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

5.  Phase I study of arsenic trioxide and temozolomide in combination with radiation therapy in patients with malignant gliomas.

Authors:  Sean A Grimm; Maryanne Marymont; James P Chandler; Kenji Muro; Steven B Newman; Robert M Levy; Borko Jovanovic; Katie McCarthy; Jeffrey J Raizer
Journal:  J Neurooncol       Date:  2012-08-09       Impact factor: 4.130

6.  Isolation and characterization of tumor stem-like cells from human meningiomas.

Authors:  Dueng-Yuan Hueng; Huey-Kang Sytwu; Shih-Ming Huang; Chen Chang; Hsin-I Ma
Journal:  J Neurooncol       Date:  2010-11-30       Impact factor: 4.130

7.  Numb regulates glioma stem cell fate and growth by altering epidermal growth factor receptor and Skp1-Cullin-F-box ubiquitin ligase activity.

Authors:  Xiuli Jiang; Hongyan Xing; Tae-Min Kim; Yuchae Jung; Wei Huang; Hong Wei Yang; Shengye Song; Peter J Park; Rona S Carroll; Mark D Johnson
Journal:  Stem Cells       Date:  2012-07       Impact factor: 6.277

8.  A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas.

Authors:  Priya Kumthekar; Sean Grimm; James Chandler; Minesh Mehta; Maryanne Marymont; Robert Levy; Kenji Muro; Irene Helenowski; Katie McCarthy; Leanne Fountas; Jeffrey Raizer
Journal:  J Neurooncol       Date:  2017-05-16       Impact factor: 4.130

9.  Transcriptional profiling of dividing tumor cells detects intratumor heterogeneity linked to cell proliferation in a brain tumor model.

Authors:  Berwini B Endaya; Paula Y P Lam; Adrian C B Meedeniya; Jiri Neuzil
Journal:  Mol Oncol       Date:  2015-09-10       Impact factor: 6.603

10.  Akt and c-Myc induce stem-cell markers in mature primary p53⁻/⁻ astrocytes and render these cells gliomagenic in the brain of immunocompetent mice.

Authors:  Josefine Radke; Ginette Bortolussi; Axel Pagenstecher
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.